Login

Biotech Company To Develop Multimillion-Dollar Facility at Former Bristol Myers Campus

BeiGene Acquires 42-Acre Site in Hopewell, New Jersey, From Lincoln Equities
A rendering of the planned manufacturing campus and research and development center that biotech firm BeiGene plans for its new 42-acre site in Hopewell, New Jersey. (BeiGene)
A rendering of the planned manufacturing campus and research and development center that biotech firm BeiGene plans for its new 42-acre site in Hopewell, New Jersey. (BeiGene)
CoStar News
November 24, 2021 | 1:31 AM

A global Chinese biotech firm has completed its acquisition of part of Bristol Myers Squibb's former campus near Princeton, New Jersey, where it plans to spend several hundred million dollars to create a manufacturing and research and development center.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE


News | Biotech Company To Develop Multimillion-Dollar Facility at Former Bristol Myers Campus